Our data provide a reasonable explanation for the observed higher Notch activity in ER(−) breast tumours: the lower protein levels of GIT1 in ER(−) breast tumours not only serve as a prognostic biomarker but also lead to elevated Notch nuclear localization and activity. This evidence concerns the gene GIT1 and breast neoplasm.